tiprankstipranks
Trending News
More News >
Sorrento Therapeutics (SRNE)
OTHER OTC:SRNE

Sorrento Therapeutics (SRNE) Revenue

Compare
5,255 Followers

Sorrento Therapeutics Revenue

Sorrento Therapeutics had a revenue of 15.03M in the quarter ending Jun 30, 2023, with -7.54%. This bring the company's revenue in the last twelve months to 64.27M, Decreased 5.87%. In the fiscal year ending Dec 31, 2022, Sorrento Therapeutics had annual revenue of 62.84M with 18.78% growth.
Revenue (ttm)
64.27M
Revenue Growth
P/S Ratio
0.01
Revenue/Employee
$66,216
Employees
949
Market Cap
$882.05K

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2022
62.84M9.94M+18.78%
Dec 31, 2021
52.90M12.92M+32.31%
Dec 31, 2020
39.99M8.55M+27.21%
Dec 31, 2019
31.43M10.24M+48.31%
Dec 31, 2018
21.19M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis